Atal Realtech provides civil engineering and construction services for government and private infrastructure projects, including sports complexes, roads, and industrial buildings, while also trading in construction materials.
The company operates in a highly fragmented and competitive bidding-based industry with no evidence of proprietary technology or cost advantages, as reflected by low net margins of 4.2% and a negative cash conversion cycle.
Earnings are largely retained for working capital and general reserves rather than distributed; the company recently utilized a rights issue to raise 27 crore INR to fund growth, indicating a reliance on external equity for expansion.
The investment collapsed as the negative cash conversion cycle finally strangled operations, forcing the company to rely on continuous equity dilution to fund basic working capital. The 2025 auditor resignation proved to be a harbinger of deteriorating internal controls, while the thin 4.2% net margins were entirely consumed by rising project costs and uncollectible trade receivables. As the promoter prioritized personal remuneration and related-party transactions over shareholder distributions, the market eventually re-rated the stock to its intrinsic value, punishing the lack of free cash flow and the absence of any competitive advantage in a commoditized bidding market.
RichFakir rates Atal Realtech Ltd's business quality as mediocre — 47/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Atal Realtech Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Atal Realtech Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Atal Realtech Ltd's fair value is about ₹6 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →